{
  "retracted": false,
  "timestamp": 1505692800000,
  "updates": [
    {
      "timestamp": 1585461135344,
      "identifier": {
        "doi": "10.1186/s13045-017-0518-8"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1186/s13045-016-0243-8"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial"
}
